A detailed history of Vident Advisory, LLC transactions in Sana Biotechnology, Inc. stock. As of the latest transaction made, Vident Advisory, LLC holds 28,939 shares of SANA stock, worth $98,681. This represents 0.0% of its overall portfolio holdings.

Number of Shares
28,939
Previous 27,059 6.95%
Holding current value
$98,681
Previous $271 Million 41.61%
% of portfolio
0.0%
Previous 0.01%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$5.23 - $10.44 $9,832 - $19,627
1,880 Added 6.95%
28,939 $158 Million
Q1 2024

May 14, 2024

BUY
$4.2 - $11.27 $7,933 - $21,289
1,889 Added 7.5%
27,059 $271 Million
Q4 2023

Feb 14, 2024

BUY
$2.8 - $4.55 $13,098 - $21,284
4,678 Added 22.83%
25,170 $103 Million
Q3 2023

Feb 21, 2024

SELL
$3.77 - $6.23 $56,263 - $92,976
-14,924 Reduced 59.29%
10,246 $39.7 Million
Q3 2023

Nov 14, 2023

BUY
$3.77 - $6.23 $77,254 - $127,665
20,492 New
20,492 $79.3 Million

Others Institutions Holding SANA

About Sana Biotechnology, Inc.


  • Ticker SANA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 190,232,000
  • Market Cap $649M
  • Description
  • Sana Biotechnology, Inc., a biotechnology company, focuses on utilizing engineered cells as medicines. The company develops ex vivo and in vivo cell engineering platforms for various therapeutic areas with unmet treatment needs, including oncology, diabetes, central nervous system disorders, cardiovascular diseases, genetic disorders, and others...
More about SANA
Track This Portfolio

Track Vident Advisory, LLC Portfolio

Follow Vident Advisory, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vident Advisory, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Vident Advisory, LLC with notifications on news.